The originality of this study lies in evaluating the prognostic value of GCR, SGK1, and Bcl-2 in the Breast Cancer Care in Chicago (BCCC) cohort, a multiethnic population of incident breast cancer cases with archived biological samples and linked clinical, genetic ancestry, survival, and sociodemographic data. This evidence concerns the gene NR3C1 and breast cancer.